BOSTON, Feb. 21,
2024 /PRNewswire/ -- Haemonetics Corporation (NYSE:
HAE) announced that Chris Simon,
President and CEO, will participate in a fireside chat with
investors at the Raymond James 45th Annual Institutional Investors
Conference on Tuesday, March 5, 2024
at 7:30 a.m. ET.
The public may access a live webcast of the fireside chat at
Haemonetics' Investor Relations website or at the following
link: https://wsw.com/webcast/rj129/hae/1445840. A replay of
the recorded webcast will become accessible 12 hours after the
event and will be available for 90 days on Haemonetics' Investor
Relations website.
About Haemonetics
Haemonetics (NYSE: HAE) is a global healthcare company dedicated
to providing a suite of innovative medical products and solutions
for customers, to help them improve patient care and reduce the
cost of healthcare. Our technology addresses important medical
markets: blood and plasma component collection, the surgical suite,
and hospital transfusion services. To learn more about Haemonetics,
visit www.haemonetics.com.
Investor
Contacts:
|
|
Olga Guyette, Sr.
Director-Investor Relations & Treasury
|
David Trenk,
Manager-Investor Relations
|
(781)
356-9763
|
(203)
733-4987
|
olga.guyette@haemonetics.com
|
david.trenk@haemonetics.com
|
|
|
Media
Contact:
|
|
Josh Gitelson,
Director-Global Communications
|
|
(781)
356-9776
|
|
josh.gitelson@haemonetics.com
|
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/haemonetics-to-present-at-raymond-james-45th-annual-institutional-investors-conference-302068095.html
SOURCE Haemonetics Corporation